Multiple Sclerosis Clinical Trial
Official title:
The Impact of Motor Rehabilitation on the Dynamic Properties of the Brain: Towards the Individual Tailoring of Therapeutic Interventions in Multiple Sclerosis Patients
Verified date | July 2018 |
Source | Fondazione Italiana Sclerosi Multipla |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Motor learning can induce significant changes in the human brain through neural plasticity
processes, which play a crucial role in the brain functional reorganization in response to
external stimuli and/or to pathological conditions. For example, people with multiple
sclerosis present motor deficits often associated with cerebral activity alteration. However,
whether these brain activation changes contribute to or protect against motor performance
deficits still needs to be determined.
Moreover, rehabilitation protocols could be designed to obtain efficient brain adaptation to
preserve patients' outcome, but consistent data on the real efficacy of rehabilitative
procedures are lacking, in particular concerning the rehabilitation effect on brain networks.
Therefore, this project focuses on the degree to which imaging measures of functional brain
activity can give new hints on the effects of motor rehabilitative protocols in multiple
sclerosis patients' performance. Particularly, the investigator's aim is to investigate the
effects of upper limb rehabilitation, focused on hand motor function, and the correlation
between motor performance and functional magnetic resonance data.
Status | Completed |
Enrollment | 30 |
Est. completion date | March 4, 2015 |
Est. primary completion date | December 22, 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Multiple sclerosis diagnosis according to McDonald criteria - right handedness as assessed by the Edinburgh Handedness Inventory - absence of relapses in the last three months - mild or moderate sensorimotor impairment in one or both upper limbs as evaluated by means of the Medical Research Council scale (grade 3-4) Exclusion Criteria: - steroid-use or a worsening of the Expanded Disability Status Scale (EDSS) score in the last three months - psychiatric disorders - severe cognitive impairment - magnetic resonance imaging contraindications |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Fondazione Italiana Sclerosi Multipla | Universita degli Studi di Genova |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the time to perform the Nine Hole Peg Test (NHPT) | The NHPT is a brief, standardized, quantitative test of upper extremity function, requiring participants to repeatedly place and then remove nine pegs into nine holes, one at a time, as quickly as possible. | Baseline and 8 weeks | |
Secondary | Score obtained at the Action Research Arm Test (ARAT) | The Action Research Arm Test is an observational measure used to assess upper extremity performance (coordination, dexterity and functioning). The scale ranges from 0 to 57, with higher scores indicating better outcomes. Items are categorized into four subscales: grasp (score 0-18) , grip (0-12), pinch (0-18) and gross movement (0-9) which are arranged in order of decreasing difficulty, with the most difficult task examined first, followed by the least difficult task. | Baseline and 8 weeks | |
Secondary | Grip and pinch strength | Force applied by the hand and the fingers measured by means of specific dynamometers | Baseline and 8 weeks | |
Secondary | Brain activity (blood-oxygenation-level dependent signal) | Task-related brain activations assessed by means of functional magnetic resonance imaging during a finger-to-thumb opposition sequence | Baseline and 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |